Fracture risk associated with parkinsonism and anti-Parkinson drugs

Calcified Tissue International

Volumn 81, Issue 3, 2007, Pages 153-161

  Vestergaard, Peter ^a   Rejnmark, Lars ^a   Mosekilde, Leif ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Anti Parkinson drug; Fracture risk; Parkinsonism

Indexed keywords

ANTIPARKINSON AGENT; CARBIDOPA; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; FRACTURE; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGE FACTORS; ANTIPARKINSON AGENTS; CARBIDOPA; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; DOPAMINE AGONISTS; ENZYME INHIBITORS; FEMALE; FRACTURES, BONE; HUMANS; LEVODOPA; MALE; MONOAMINE OXIDASE INHIBITORS; PARKINSONIAN DISORDERS; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 34548511817     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-007-9065-6     Document Type: Article

References (30)

1. Genever RW, Downes TW, Medcalf P (2005) Fracture rates in Parkinson's disease compared with age- and gender-matched controls: a retrospective cohort study. Age Ageing 34:21-24
2. Johnell O, Melton LJ III, Atkinson EJ, O'Fallon WM, Kurland LT (1992) Fracture risk in patients with parkinsonism: a population-based study in Olmsted County, Minnesota. Age Ageing 21:32-38
3. Taylor BC, Schreiner PJ, Stone KL, Fink HA, Cummings SR, Nevitt MC, Bowman PJ, Ensrud KE (2004) Long-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fractures. J Am Geriatr Soc 52:1479-1486
4. Wielinski CL, Erickson-Davis C, Wichmann R, Walde-Douglas M, Parashos SA (2005) Falls and injuries resulting from falls among patients with Parkinson's disease and other parkinsonian syndromes. Mov Disord 20:410-415
5. Williams DR, Watt HC, Lees AJ (2006) Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study. J Neurol Neurosurg Psychiatry 77:468-473
6. Melton LJ III, Leibson CL, Achenbach SJ, Bower JH, Maraganore DM, Oberg AL, Rocca WA (2006) Fracture risk after the diagnosis of Parkinson's disease: influence of concomitant dementia. Mov Disord 21:1361-1367
7. Yamanashi A, Yamazaki K, Kanamori M, Mochizuki K, Okamoto S, Koide Y, Kin K, Nagano A (2005) Assessment of risk factors for second hip fractures in Japanese elderly. Osteoporos Int 16:1239-1246
8. Di Monaco M, Vallero F, Di Monaco R, Tappero R, Cavanna A (2006) Bone mineral density in hip-fracture patients with Parkinson's disease: a case-control study. Arch Phys Med Rehabil 87:1459-1462
9. Taggart H, Crawford V (1995) Reduced bone density of the hip in elderly patients with Parkinson's disease. Age Ageing 24:326-328
10. Sato Y, Kikuyama M, Oizumi K (1997) High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology 49:1273-1278
11. 3 in elderly patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 66:64-68
12. Sato Y, Honda Y, Kaji M, Asoh T, Hosokawa K, Kondo I, Satoh K (2002) Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency. Bone 31:114-118
13. Sato Y, Kaji M, Tsuru T, Oizumi K (2001) Risk factors for hip fracture among elderly patients with Parkinson's disease. J Neurol Sci 182:89-93
14. Sato Y, Iwamoto J, Kanoko T, Satoh K (2005) Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson's disease. Am J Med 118:1250-1255
15. Dorrington J, Gore-Langton RE (1981) Prolactin inhibits oestrogen synthesis in the ovary. Nature 290:600-602
16. Frank L (2000) Epidemiology. When an entire country is a cohort. Science 287:2398-2399
17. Andersen TF, Madsen M, Jørgensen J, Mellemkjær L, Olsen JH (1999) The Danish National Hospital Register. Dan Med Bull 46:263-268
18. Vestergaard P, Mosekilde L (2002) Fracture risk in patients with celiac disease, Crohn's disease, and ulcerative colitis: a nation-wide follow-up study in 16,416 patients in Denmark. Am J Epidemiol 156:1-10
19. Wacholder S, McLaughlin JK, Silverman DT, Mandel JS (1992) Selection of controls in case-control studies. I. Principles. Am J Epidemiol 135:1019-1028
20. Capella D (1993) Descriptive tools and analysis. In: Dukes MNG (ed) Drug utilization studies: methods and uses. WHO Regional Publications, European Series 45, Copenhagen, pp 55-78
21. Nielsen GL, Sørensen HT, Zhou W, Steffensen FH, Olsen J (1997) The pharmaco-epidemiologic prescription database of north Jutland. Int J Risk Saf Med 10:203-205
22. Munk-Jørgensen P, Mortensen PB (1997) The Danish Psychiatric Central Register. Dan Med Bull 44:82-84
23. Miettinen OS (1985) Theoretical epidemiology: principles of occurrence research in medicine. Wiley, New York
24. Vestergaard P, Mollerup CL, Frøkjær VG, Christiansen P, Blichert-Toft M, Mosekilde L (2000) Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ 321:598-602
25. Vestergaard P, Rejnmark L, Mosekilde L (2006) Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 17:807-816
26. Ensrud KE, Blackwell TL, Mangione CM, Bowman PJ, Whooley MA, Bauer DC, Schwartz AV, Hanlon JT, Nevitt MC (2002) Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc 50:1629-1637
27. Pollock BG (1999) Adverse reactions of antidepressants in elderly patients. J Clin Psychiatry 60 Suppl 20:4-8
28. Steiger MJ, Thompson PD, Marsden CD (1996) Disordered axial movement in Parkinson's disease. J Neurol Neurosurg Psychiatry 61:645-648
29. Aita JF (1982) Why patients with Parkinson's disease fall. JAMA 247:515-516
30. Sambrook PN, Cameron ID, Chen JS, Cumming RG, Lord SR, March LM, Schwarz J, Seibel MJ, Simpson JM (2007) Influence of fall related factors and bone strength on fracture risk in the frail elderly. Osteoporos Int 18:603-610